SHIKIAR ASSET MANAGEMENT INC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 41 filers reported holding UROGEN PHARMA LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
SHIKIAR ASSET MANAGEMENT INC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$466
+35.5%
33,2500.0%0.16%
+45.9%
Q2 2023$344
+12.1%
33,2500.0%0.11%
+1.8%
Q1 2023$307
-99.9%
33,2500.0%0.11%
-1.8%
Q3 2022$277,000
+1.8%
33,2500.0%0.11%
+5.7%
Q2 2022$272,000
-6.2%
33,2500.0%0.10%
+28.0%
Q1 2022$290,000
-8.5%
33,250
-0.3%
0.08%
+1.2%
Q4 2021$317,000
-43.5%
33,3500.0%0.08%
-48.7%
Q3 2021$561,000
-31.2%
33,350
-37.5%
0.16%
-31.3%
Q2 2021$815,000
+18.3%
53,350
+50.9%
0.23%
-1.3%
Q1 2021$689,000
-4.3%
35,350
-11.5%
0.23%
-10.0%
Q4 2020$720,000
-16.2%
39,950
-10.3%
0.26%
-21.5%
Q3 2020$859,000
-35.8%
44,550
-12.9%
0.33%
-45.8%
Q2 2020$1,337,000
+42.7%
51,175
-2.6%
0.61%
-3.2%
Q1 2020$937,000
-58.1%
52,550
-21.6%
0.63%
-15.1%
Q4 2019$2,237,000
+41.6%
67,025
+1.1%
0.74%
+18.6%
Q3 2019$1,580,000
-31.8%
66,300
+2.8%
0.62%
-31.1%
Q2 2019$2,318,000
-21.8%
64,500
-19.7%
0.91%
-27.0%
Q1 2019$2,966,000
-7.5%
80,300
+7.9%
1.24%
-25.9%
Q4 2018$3,206,000
-13.4%
74,450
-5.1%
1.68%
+16.1%
Q3 2018$3,704,000
+54.7%
78,425
+63.0%
1.44%
+44.0%
Q2 2018$2,395,000
+5.7%
48,125
+5.6%
1.00%
-2.8%
Q1 2018$2,265,000
+189.6%
45,575
+116.8%
1.03%
+181.7%
Q4 2017$782,000
+17.6%
21,025
-0.4%
0.37%
+26.6%
Q3 2017$665,00021,1000.29%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2017
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders